As the anticipation for ASH 2023 builds, Professor Graham Jackson, consultant haematologist and Myeloma UK’s Chief Clinical and Scientific Advisor, sheds light on the top abstracts to watch, offering a curated glimpse into the forefront of myeloma research.
In a year of exceptional contributions to myeloma care, we are excited to announce that Ysbyty Gwynedd in Bangor has been honoured with the Myeloma UK’s Clinical Service Excellence Programme award for their innovative approaches to myeloma treatment.
This latest update presents critical developments in myeloma treatment appraisals by NICE and the SMC.
Stay informed about the latest recommendations, appeal hearings, and upcoming assessments shaping the treatment options for patients and healthcare professionals.
New NICE guidelines on managing cancer-related spinal cord compression (SCC) have been published, with Myeloma UK actively participating in their development. The guidelines aim to improve early diagnosis and treatment of SCC to prevent neurological injury and improve prognosis.
New treatment appraisals continue to come through the Health Technology Appraisal (HTA) pipeline.
Myeloma UK is involved in seven active appraisals between the National Institute for Healthcare Excellence (NICE) and the Scottish Medicines Consortium (SMC).
Myeloma UK has launched a new, accessible, inclusive website designed for and by the myeloma community.
Discover the enhanced accessibility toolbar, improved search functions, and dedicated hub pages for healthcare professionals.
Researchers are recruiting newly diagnosed myeloma patients for a UK study, RADAR, to investigate whether personalised treatments could optimise patient care, reduce the risk of early relapse, and increase life expectancy.
11 exceptional hospitals have been awarded the prestigious CSEP accreditation, recognising their outstanding contributions to myeloma care.
Explore some of the outstanding achievements and highlights that showcase these hospitals’ commitment to exceptional patient care.
Myeloma UK’s health services research team (HSR) had a prominent presence at the British Society of Haematology (BSH) Annual Conference in Birmingham this year, showcasing their groundbreaking research.
With a strong focus on addressing the unmet needs of patients, HSR presented their findings on shared decision-making, imaging at myeloma diagnosis, and patient-centric care.
